The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

Dec. 20, 2019
Applicant:

Apollo Neuroscience, Inc., Pittsburgh, PA (US);

Inventors:

David Mayer Lowell Rabin, Pittsburgh, PA (US);

Kathryn Fantauzzi, Pittsburgh, PA (US);

Assignee:

Apollo Neuroscience, Inc., Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 21/02 (2006.01); G16H 20/70 (2018.01); A61H 1/00 (2006.01); G16H 20/00 (2018.01); A61H 23/00 (2006.01); G16H 20/30 (2018.01); G16H 40/67 (2018.01); G16H 10/60 (2018.01); G16H 50/30 (2018.01); A61B 5/00 (2006.01); G05B 19/416 (2006.01); A61M 21/00 (2006.01);
U.S. Cl.
CPC ...
A61M 21/02 (2013.01); A61B 5/4812 (2013.01); A61H 1/00 (2013.01); A61H 23/00 (2013.01); G05B 19/416 (2013.01); G16H 10/60 (2018.01); G16H 20/00 (2018.01); G16H 20/30 (2018.01); G16H 20/70 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); A61H 2201/165 (2013.01); A61H 2201/5005 (2013.01); A61H 2201/5007 (2013.01); A61H 2201/5023 (2013.01); A61H 2230/045 (2013.01); A61H 2230/085 (2013.01); A61H 2230/105 (2013.01); A61H 2230/203 (2013.01); A61H 2230/305 (2013.01); A61H 2230/425 (2013.01); A61M 2021/0016 (2013.01); A61M 2021/0022 (2013.01); A61M 2021/0044 (2013.01); A61M 2205/05 (2013.01); A61M 2205/3303 (2013.01); G05B 2219/37032 (2013.01);
Abstract

Systems and methods to mitigate negative effects of a drug in a treatment of a mental health condition include administering a drug to a subject in a therapy session; determining effects of the drug, the effects being counterproductive to the therapy session; and providing tactile stimulation to a subject with a stimulation device that generates transcutaneous vibratory output to be applied to a portion of a body of the subject during the therapy session, wherein the transcutaneous vibratory output is selected to reduce the counterproductive effects of the drug.


Find Patent Forward Citations

Loading…